Premium
Somatostatin inhibits VIP‐ and isoproterenol‐stimulated cyclic AMP accumulation in rat prostatic epithelial cells
Author(s) -
Carmena M.J.,
Sancho J.I.,
Fernández-Gonzalez M.A.,
Escudero F.,
Prieto J.C.
Publication year - 1987
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/0014-5793(87)81021-9
Subject(s) - vasoactive intestinal peptide , somatostatin , endocrinology , medicine , basal (medicine) , chemistry , epithelium , isoprenaline , neuropeptide , biology , receptor , stimulation , genetics , insulin
The dual regulation of cyclic AMP accumulation was studied in rat prostatic epithelial cells incubated with somatostatin, vasoactive intestinal peptide (VIP), and the β‐adrenergic agent isoproterenol. Somatostatin noncompetitively inhibited the stimulatory effect of VIP and isoproterenol, but it did not alter basal cyclic AMP levels. In addition to the multifactorial regulation of the cyclic AMP system in rat prostatic epithelium, these results suggest that somatostatin may play a physiological role at this level.